Literature DB >> 21243329

[Xeroderma pigmentosum (XP) : A genetic disease sheds light on UV-induced skin cancer].

B Emmert1, E Hallier, M P Schön, S Emmert.   

Abstract

The recessively inherited nucleotide excision repair (NER) defect syndrome xeroderma pigmentosum (XP) serves as a model disease for UV-induced skin cancer. XP is characterized by sun-sensitivity, freckling, and poikilodermic skin changes in sun-exposed areas, and a more than 1000-fold increased risk of skin cancer including melanoma as well as basal and squamous cell carcinomas. Seven XP complementation groups (XP-A to XP-G) are known to date representing the defective genes in XP patients. An additional "variant" form (XPV) which is clinically indistinguishable from the complementation groups exhibits defective translesional synthesis. An enhanced understanding of skin cancer development in general can help to identify individuals at an increased risk who should take special precautions, for example to avoid occupational exposures. The position of skin cancer induced by UV-light as an occupational disease in the ordinance on industrial diseases (BKV) is currently a topic of research and discussion in Germany.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21243329     DOI: 10.1007/s00105-010-2050-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  16 in total

1.  Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome.

Authors:  Kyu-Seon Oh; Sikandar G Khan; N G J Jaspers; Anja Raams; Takahiro Ueda; Alan Lehmann; Peter S Friedmann; Steffen Emmert; Alexi Gratchev; Katherine Lachlan; Anneke Lucassan; Carl C Baker; Kenneth H Kraemer
Journal:  Hum Mutat       Date:  2006-11       Impact factor: 4.878

2.  Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1% of the Japanese population.

Authors:  Yuko Hirai; Yoshiaki Kodama; Shin-Ichi Moriwaki; Asao Noda; Harry M Cullings; Donald G Macphee; Kazunori Kodama; Kiyohiko Mabuchi; Kenneth H Kraemer; Charles E Land; Nori Nakamura
Journal:  Mutat Res       Date:  2006-08-14       Impact factor: 2.433

Review 3.  Syndromes with genetic instability: model diseases for (skin) cancerogenesis.

Authors:  Steffen Emmert; Diana Leibeling; Thomas M Rünger
Journal:  J Dtsch Dermatol Ges       Date:  2006-09       Impact factor: 5.584

4.  Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.

Authors:  Porcia T Bradford; Alisa M Goldstein; Deborah Tamura; Sikandar G Khan; Takahiro Ueda; Jennifer Boyle; Kyu-Seon Oh; Kyoko Imoto; Hiroki Inui; Shin-Ichi Moriwaki; Steffen Emmert; Kristen M Pike; Arati Raziuddin; Teri M Plona; John J DiGiovanna; Margaret A Tucker; Kenneth H Kraemer
Journal:  J Med Genet       Date:  2010-11-19       Impact factor: 6.318

5.  Xeroderma pigmentosum.

Authors:  K H Kraemer; H Slor
Journal:  Clin Dermatol       Date:  1985 Jan-Mar       Impact factor: 3.541

6.  XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms.

Authors:  Sikandar G Khan; Kyu-Seon Oh; Steffen Emmert; Kyoko Imoto; Deborah Tamura; John J Digiovanna; Tala Shahlavi; Najealicka Armstrong; Carl C Baker; Marcy Neuburg; Chris Zalewski; Carmen Brewer; Edythe Wiggs; Raphael Schiffmann; Kenneth H Kraemer
Journal:  DNA Repair (Amst)       Date:  2008-11-14

Review 7.  The causes of skin cancer: a comprehensive review.

Authors:  Rao N Saladi; Andrea N Persaud
Journal:  Drugs Today (Barc)       Date:  2005-01       Impact factor: 2.245

8.  Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases.

Authors:  K H Kraemer; M M Lee; J Scotto
Journal:  Arch Dermatol       Date:  1987-02

9.  Functional DNA repair system analysis in haematopoietic progenitor cells using host cell reactivation.

Authors:  K M Thoms; J Baesecke; B Emmert; J Hermann; T Roedling; P Laspe; D Leibeling; L Truemper; S Emmert
Journal:  Scand J Clin Lab Invest       Date:  2007       Impact factor: 1.713

Review 10.  Nucleotide excision repair and cancer.

Authors:  Diana Leibeling; Petra Laspe; Steffen Emmert
Journal:  J Mol Histol       Date:  2006-07-20       Impact factor: 3.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.